GLUE
Monte Rosa Therapeutics, Inc.
$18.81
AlphaVal Unavailable
AlphaVal: GLUE has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.